Company / FCF Margin
CHINA PHARMA HOLDINGS, INC. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
2.1%
FY2025
5-year range
-10.1% / 2.1%
FY2021-FY2025
Trend
+121.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -10.1% to 2.1% over the past 2 years.
Based on SEC 10-K filings.
2.1% in FY2025 with a 5-year CAGR of -2.2%.
Improved from -10.1% to 2.1% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +12.2pp
- 5-Year Change
- -2.2pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin increased 121.2% year-over-year.
- Peak fcf margin was recorded in FY2016.
- Lowest fcf margin in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 2.1% | +121.2% |
| FY2024 | -10.1% | +0.0% |
| FY2023 | -10.1% | -1.3% |
| FY2022 | -10.0% | -19.6% |
| FY2021 | -8.4% | -293.8% |
| FY2020 | 4.3% | -70.9% |
| FY2019 | 14.8% | +178.6% |
| FY2018 | 5.3% | -69.3% |
| FY2017 | 17.4% | -12.5% |
| FY2016 | 19.8% | +328.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026